Official Disclaimer and Notice to the Esteemed Public

The entity known as KATSULA PHARMA hereby solemnly declares that it operates as a supplier of chemical compounds strictly intended for scientific research, analysis, and educational purposes. The products distributed under this banner do not constitute medicines, nor are they authorized for human or veterinary use within any jurisdiction.

• Under no circumstances shall KATSULA PHARMA be construed as a manufacturer or distributor of medicinal products.
• All substances provided are strictly confined to non-therapeutic applications, including laboratory investigation and quality control.
• KATSULA PHARMA neither holds nor claims any licenses relating to pharmaceutical manufacture, wholesale distribution, or retail pharmacy.
• The operations of KATSULA PHARMA comply fully with all prevailing European legislation governing chemical safety, including, but not limited to, REACH and CLP regulations.
• Physical delivery of products is subject to thorough compliance with regulatory documentation requirements.
• Access to products and services is strictly prohibited to persons under the age of eighteen, unless express permission is granted.

It must be unequivocally understood that any reference to active pharmaceutical ingredients (APIs) or similar terminology is for classification purposes only and must not be interpreted as endorsement of safety, efficacy, or medical suitability.

Conditions of Use

• Accessing and utilizing the services of KATSULA PHARMA via katsulapharma.com/indexema.html, you affirm your understanding and acceptance of these conditions.
• Any violation or deviation from these terms may result in the immediate revocation of access privileges without prior notification.
• For guidance on proper chemical disposal, the public is directed to medsdisposal.eu.

• All formal communications, notifications, and matters of procedural relevance, interested parties are hereby instructed to address their correspondence directly to the appointed representatives of the European Medicines Agency (EMA), including members and alternates of the Pharmacovigilance Risk Assessment Committee (PRAC).EMA(European Medicines Agency) and PRAC(pharmacovigilance-risk-assessment-committee-practices).
• KATSULA PHARMA through email address; admin@katsulapharma.com